Protocol Title: A Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Randomized Clinical Trial Investigating the Efficacy and Safety of a 10-Day Oral Nimsai Herbal Treatment in Patients with Grade 2-3 Hemorrhoids, Based on the War-Drill Model and the Sine Qua Non Hypothesis Protocol Number: NA-2024-01 Protocol Version: 1.1 Date: October 14,...
.box { border: 1px solid #000; padding: 10px; margin: 10px auto; width: 300px; text-align:...
Section/topicNoCONSORT 2025 checklist item descriptionReported on page no.Title and abstractTitle and abstractTitle and abstractTitle and structured abstract1aIdentification as a randomised trialTitle, AbstractTitle and structured abstract1bStructured summary of the trial design, methods, results, and conclusionsAbstractOpen scienceOpen scienceOpen scienceTrial registration2Name of trial registry, identifying number (with URL)...
Protocol Title: A Prospective, Double-Blind Diagnostic Accuracy Study of the Parola Phenomenon in Patients with Symptomatic Hemorrhoids Protocol Number: S1 (Supplementary Protocol 1) Protocol Version: 1.0 Date: Oct 14, 2021 Investigators: Cem Atabiner, Nimsai Academia Principal Investigator Nimsai Academia Anal Fissure-Hemorrhoid Research Team Affiliation: Nimsai Academia, Türkiye Corresponding Investigator: Cem Atabiner, info@nimsai.com 1. Introduction and Rationale The...
Product Name: Nimsai Herbal Protocol Number: NA-2024-01 Date: Oct 14, 2021 1. INTRODUCTION TO NIMSAI HERBAL Nimsai Herbal is a novel, proprietary oral herbal formulation developed by Nimsai Academia for the systemic management of hemorrhoidal disease. It is hypothesized to target underlying venous congestion, a critical factor in hemorrhoid...
Product Name: Nimsai Herbal Protocol Number: NA-2024-01 Date: Oct 14, 2021 1. INTRODUCTION TO NIMSAI HERBAL Nimsai Herbal is a novel, proprietary oral herbal formulation developed by Nimsai Academia for the systemic management of hemorrhoidal disease. It is hypothesized to target underlying venous congestion, a critical factor in hemorrhoid...
Study Protocol Number: NA-2024-01 Participant ID: Site ID: CRF Section 1: Screening & Baseline Demographics (Day 0) Participant ID: ___________ Date of Birth: __/__/____ (DD/MM/YYYY) Age (Years): ____ Gender: [ ] Male [ ] Female Ethnicity: [ ] Caucasian [ ] Asian [ ] African [ ] Other: ______ Medical History (Relevant): IBD: [...
Protocol Title: A Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Randomized Clinical Trial Investigating the Efficacy and Safety of a 10-Day Oral Nimsai Herbal Treatment in Patients with Grade 2-3 Hemorrhoids, Based on the War-Drill Model and the Sine Qua Non Hypothesis Protocol Number: NA-2024-01 Version: 1.1 Date: Oct 14, 2021 Investigator:...